Thuja Occidentalis 200 [hp_C]/1

Thuja Occidentalis · PELLET · Hahnemann Laboratories, INC.

1 Recall on Record

Plain English

Thuja Occidentalis is a pellet containing thuja occidentalis at 200 [hp_C]/1, taken oral. Manufactured by Hahnemann Laboratories, INC..

Key Facts

1 Recall on Record

Class II08/20/2021

Washington Homeopathic Products, Inc.

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

TerminatedVoluntary: Firm initiated

FDA FAERS database · These are reported events, not confirmed side effects

agranulocytosis1 reports

flatulence1 reports

haematochezia1 reports

irritability1 reports

treatment failure1 reports

Source: FDA Drug Label (SPL)For healthcare professionals

USE: Condition listed above or as directed by a physician.

DIRECTIONS: (adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.

WARNINGS: Stop use and ask a physician if symptoms persist for more than 3 days or worsen.

Thuja Occidentalis contains Thuja Occidentalis. It is a pellet taken oral. Consult your doctor for specific uses.

Thuja Occidentalis is not classified as a controlled substance by the DEA.

The generic name for Thuja Occidentalis is Thuja Occidentalis. There are 11 other brand versions of Thuja Occidentalis.

The NDC (National Drug Code) for Thuja Occidentalis 200 [hp_C]/1 is 37662-2557, listed by Hahnemann Laboratories, INC..

Product NDC

37662-2557

Package NDC

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)